In the News

Overactive bladder drug may not increase risk for CV events

Patients with overactive bladder who were dispensed mirabegron did not have an increased risk for cardiovascular events compared with other treatments, according to a study published in JAMA Internal Medicine.

July 15, 2019 | Cardiology Today | News Article | Associated Research


Nearly 400 people in Ontario died of opioid overdose last summer, says province

Meanwhile, a new report from the Ontario Drug Policy Research Network looked at 1,337 opioid-related deaths in the province from July 2017 to June 2018.

June 17, 2019 | CTV News | News Article | Associated Research


London area ranks third in province for naloxone distribution rate

Of the 147,303 publicly funded naloxone kits distributed across the province between July 2017 and June 2018, 8,657 were handed out in the Middlesex-London Health Unit coverage area — a rate of 1,813 per 100,000 people — a new study by the ODPRN says.

June 5, 2019 | The London Free Press | News Article | Associated Research


Three research teams at St. Michael’s to receive federal funding to address the opioid crisis

Using Ontario’s health record databases, Drs. Gomes and Antoniou, scientists at the Li Ka Shing Knowledge Institute and ICES, and members of their team will be studying how successful the program has been in providing naloxone to eligible individuals.

May 15, 2019 | St. Michael’s Newsroom | News Article | Associated Research


Archive: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | Older

Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.